Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemostasis and cancer.

J L Francis

    Medical Laboratory Sciences
    |October 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Cancer patients show higher rates of blood clots and bleeding issues. The study explores how the hemostatic system, involving fibrin formation, impacts cancer growth and spread, with potential therapeutic implications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CalDAG-GEFI deficiency protects mice from FcγRIIa-mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes.

    Journal of thrombosis and haemostasis : JTH·2014
    Same author

    Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?

    Journal of thrombosis and haemostasis : JTH·2013
    Same author

    Assessment of protein C anticoagulant pathway by thrombin generation assay in the presence of endothelial cells.

    Journal of thrombosis and haemostasis : JTH·2013
    Same author

    Assessing the role of platelet activation in bevacizumab associated thrombosis.

    Swiss medical weekly·2011
    Same author

    Effects of nifedipine and propranolol on whole blood platelet aggregation.

    Platelets·2010
    Same author

    Platelet Aggregation in Primary Raynaud's Phenomenon and the Effect of Enalapril Administration.

    Platelets·2010

    Area of Science:

    • Oncology
    • Hematology
    • Biomedical Research

    Background:

    • Patients with cancer frequently experience thromboembolic disease and hemostatic abnormalities.
    • The hemostatic system plays a significant role in the progression and metastasis of malignant diseases.
    • Peri-tumour fibrin deposition is a key factor in cancer spread, though its exact mechanisms require further elucidation.

    Purpose of the Study:

    • To investigate the involvement of the hemostatic system in cancer growth and metastasis.
    • To explore the role of fibrin formation in malignant dissemination.
    • To understand the mechanisms of peri-tumour fibrin deposition and the involvement of haemostatic components in neovascularisation and angiogenesis.

    Main Methods:

    • Review of existing evidence on hemostatic abnormalities in cancer patients.

    Related Experiment Videos

  • Analysis of the role of fibrin formation in tumor spread.
  • Investigation of potential mechanisms of peri-tumour fibrin deposition, including vascular permeability and procoagulants.
  • Examination of the involvement of haemostatic components in neovascularisation and angiogenesis.

    • Main Results:

    • Anti-hemostatic agents have shown promising results in experimental tumor models.
    • Clinical trials involving anti-hemostatic agents in cancer patients have been initiated.
    • Peri-tumour fibrin formation is implicated as a critical factor in cancer cell dissemination.
    • Potential mechanisms for fibrin deposition involve altered vascular permeability and the presence of tumor/macrophage procoagulants.

    Conclusions:

    • The hemostatic system is intricately linked to cancer progression and metastasis.
    • Targeting the hemostatic system with anti-hemostatic agents presents a potential therapeutic strategy for cancer.
    • Further research is needed to fully elucidate the mechanisms of peri-tumour fibrin deposition and the broader role of hemostasis in cancer biology.